Journal of the Formosan Medical Association · 2019 · 26 citations · 24 references
MedicineImmunologyPediatricsImmunopathologyMolecular VirologyTransplant ImmunologyLiver Transplant ImmunosuppressionLiver TransplantationPediatric Clinical ImmunologyPediatric Liver DiseasePediatric TransplantationTransplant RejectionImmunosuppression Level MonitoringInfection Risk FactorsKaplan-meier Survival EstimatesPosttransplant Lymphoproliferative DisorderTacrolimus ExposureTacrolimus TherapyTransplant Immunology In ChildrenViral Load Assessment
BACKGROUND/PURPOSE: This study is aimed to investigate the risk factors and clinical characteristics of posttransplant lymphoproliferative disorder (PTLD) after conducting Epstein-Barr virus (EBV) viral load monitoring in pediatric liver transplant (LT) patients in Taiwan, where EBV infection is endemic. METHODS: From 2007 to 2013, pediatric LT recipients who underwent EBV viral load monitoring within 3 months after LT were recruited in this study. The impact of clinical parameters-including age at LT, sex, peak EBV viral load and immunosuppressant levels after LT-on the risk of PTLD were assessed. RESULTS: A total 39 patients underwent LT at a median age of 1.3 years (range: 0.6-14.0 years), and 5 patients developed PTLD during follow-up. Cox's proportional-hazards model identified two predictors of PTLD: peak EBV viral load within 3 months of LT >4100 copies/μg peripheral blood mononuclear cells (PBMC) DNA and peak tacrolimus level within 3 months of LT >14.8 ng/mL (Hazard ratio = 17.14 and 11.54, P = 0.02 and 0.03, respectively). Kaplan-Meier survival analysis revealed significant higher cumulative incidence rates of PTLD (27.3% and 41.8% at 0.3 and 1.2 years after LT) in subjects with peak EBV viral load >4100 copies/μg PBMC DNA within 3 months after LT. (P = 0.001, log-rank test). CONCLUSION: Close monitoring of EBV viral load within 3 months after LT is helpful to predict a high risk of PTLD. Tapering of immunosuppressants is suggested if the EBV viral load is >4100 copies/μg PBMC DNA in LT children.
24
Joost W. J. van Esser, Hubert G.M. Niesters, Bronno van der Holt et al. · Blood · 2002 · 401 citations · Full text
Prompt versus preemptive intervention for EBV lymphoproliferative disease
Hans‐Joachim Wagner, Yee Chung Cheng, M. Helen Huls et al. · Blood · 2004 · 225 citations · Full text